Ramiro Ribeiro is Chief Medical Officer at EyePoint, Inc. (EYPT). They have made 6 open-market trades across 1 company since 2025, most recently 2026-06-30.
CIK 0002013623
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EYPT | 2,438 | $952 |
Shares reported on the most recent Form 4, priced at the 2026-07-02 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EYPT | SELL | 2026-06-30 | 2026-07-02 | $15.01 | $73K | -2.1% | -12.2% | -77.0% |
| EYPT | SELL | 2026-04-17 | 2026-04-20 | $15.00 | $37K | -12.3% | -16.8% | -15.8% |
| EYPT | SELL | 2026-03-04 | 2026-03-05 | $17.87 | $44K | -8.3% | -13.5% | -18.6% |
| EYPT | SELL | 2026-02-17 | 2026-02-18 | $15.00 | $37K | +28.1% | -7.6% | -17.4% |
| EYPT | SELL | 2026-01-05 | 2026-01-07 | $17.10 | $728K | -11.2% | -24.0% | -22.5% |
| EYPT | SELL | 2025-11-11 | 2025-11-12 | $11.61 | $32K | +20.9% | +34.3% | +15.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.